 Biocept Inc NASDAQ:BIOC Biocept Inc NASDAQ:BIOC has highlighted how its CNSide cerebrospinal fluid CSF assay could improve the treatment options for brain cancer patients. The biotech has been presenting at the Molecular Precision Med Tri-Con meeting the leading international meeting for the precision medicine communitybeing held in San Diego between February 21 and 23 this year. 